Find in Library

Background: Vitamin D₃ supplements are available as tablets or oil drops, but there is no consensus as to whether either of these preparations is more effective than the other. Methods: We compared the effectiveness of tablets versus oil in raising S-25-hydroxyvitamin D (S-25-OHD) in plasma by re-analyzing data from a previously performed observational study in which immunodeficient patients with S-25-OHD concentrations <75 nmol/L were randomly prescribed vitamin D₃ tablets (1600 IU/day) or vitamin D₃ oil-drops (1500 IU/day) for twelve months. Tablets and oil were compared for the effect on S-25-OHD concentrations after 3–5 months and antibiotic use. Results: Data on S-25-OHD after ≥ 3 months was available for 137 patients treated with tablets and 69 with oil drops. Both groups exhibited a significant increase in S-25-OHD—oil-drops from 55 to 86 nmol/L and tablets from 52 to 87 nmol/L—with no difference between groups (<i>p</i> = 0.77). In a subgroup of patients without immunoglobulin replacement, vitamin D₃ supplementation with oil drops (<i>n</i> = 34) but not with tablets (<i>n</i> = 60) resulted in significantly lower antibiotic administration (<i>p</i> < 0.001 and <i>p</i> = 0.58). Conclusion: Vitamin D₃ supplementation with tablets and oil drops were equally efficient in raising S-25-OHD concentrations. Only oil drops caused a reduction in antibiotic consumption in immuno-deficient patients who did not receive immunoglobulin replacement.